Keywords: EMEA, Plavix, Sanofi-Aventis, Sun Pharmaceuticals, NovoNorm, Novo Nordisk
EMEA recalls batches of generic Plavix; Sun Pharma withdraws EU marketing application for Repaglinide SUN
Article | 26 March 2010
European Medicines Agency (EMEA) yesterday afternoon recommended a precautionary recall of batches of clopidogrel-containing medicines from Acino Pharma GmbH and ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- FDA probes two deaths possibly linked to Lilly's antipsychotic Zyprexa Relprevv
- Negative US patent ruling for Novo Nordisk on Prandin
- Aspen Pharma offers to buy GlaxoSmithKline's thrombosis brands and manufacturing site
- US Supreme Court says patent settlement can "sometimes" be illegal
- Daiichi Sankyo files for Japanese approval of Prasugrel
